FRANKLIN LAKES, N.J., Nov. 19 Collagen Matrix, Inc.announced today that it has signed an agreement with Stryker Orthopaedics forthe exclusive worldwide distribution of its NeuroMend(TM) Collagen Nerve Wrap.
NeuroMend is a resorbable, collagen-based rolled membrane matrix intendedfor use in the repair of crushed or severed peripheral nerves. NeuroMendprovides a protective environment to guide the regeneration of the nerveacross the injury or gap. The rolled membrane configuration of NeuroMendoffers the ability of a single product to approximate nerves of varyingdiameters. In addition, NeuroMend can be implanted with minimal suturing dueto the unique wrap design of the product.
"We are pleased to further our collaboration with Stryker Orthopaedics inthe area of nerve repair. Stryker's highly-skilled and focused sales andmarketing teams have already made a significant impact in the market with ourNeuroflex and NeuroMatrix products. The addition of NeuroMend providessurgeons with a much needed solution for treating crush injuries often seen intrauma cases," said Shu-Tung Li, Ph.D., Founder and CEO of Collagen Matrix.
Stryker Corporation is one of the world's leading medical technologycompanies with a broad based range of products in orthopaedics and asignificant presence in other medical specialties. Stryker works withrespected medical professionals to help people lead more active and moresatisfying lives. The company's products include implants used in jointreplacement, trauma, craniomaxillofacial and spinal surgeries; biologics;surgical, neurologic, ear, nose & throat and interventional pain equipment;endoscopic, surgical navigation, communications and digital imaging systems;as well as patient handling and emergency medical equipment. Stryker alsoprovides outpatient physical therapy services in the United States. Thecompany's website address is http://www.stryker.com.
Collagen Matrix, Inc. is a leader in the design and engineering ofcollagen- and mineral-based extracellular matrices for tissue and organ repairand regeneration. Since its inception in 1997, the Company has received manygovernment grants for the development of collagen-based matrix products in theareas of neurological, vascular, urological, and orthopedic tissueregeneration applications. The Company currently manufactures collagen- andmineral-based finished medical devices in the areas of neurosurgery, oralsurgery, orthopedic-spine surgery, and wound care. More information about theCompany can be found at www.collagenmatrix.com.
Contact: Shu-Tung Li, Ph.D. 888-405-1001, 201-405-1477
SOURCE Collagen Matrix, Inc.